What does PHARMACIE MINGNEAU do?

PHARMACIE MINGNEAU is a pharmacy in Rumes. Public Limited, started on 15 March 1991, 1 establishment.

What is the address of PHARMACIE MINGNEAU?

The registered office of PHARMACIE MINGNEAU is located at Chaussée de Douai(RS) 92, 7610 Rumes.

Is PHARMACIE MINGNEAU still active?

Yes. According to the CBE (29 October 2026) PHARMACIE MINGNEAU is active, legal situation “Normale toestand”, started on 15 March 1991.

Is PHARMACIE MINGNEAU registered on Peppol?

Yes, PHARMACIE MINGNEAU is registered on the Peppol network with ID 0208:0443686314.

What is the enterprise number of PHARMACIE MINGNEAU?

The enterprise number of PHARMACIE MINGNEAU is BE0443686314.

When was PHARMACIE MINGNEAU founded?

PHARMACIE MINGNEAU was founded on 15 March 1991.

Who are the directors of PHARMACIE MINGNEAU?

According to the 2025 annual accounts, the directors of PHARMACIE MINGNEAU are: Marc Vander Massen, Martin Vander Massen, Estelle Mingneau.

Is PHARMACIE MINGNEAU a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 March 1991; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did PHARMACIE MINGNEAU make in 2025?

PHARMACIE MINGNEAU posted a profit after taxes of € 80,038 in financial year 2025.

What is the revenue of PHARMACIE MINGNEAU?

As a small company, PHARMACIE MINGNEAU is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 408,078.

How much does an employee at PHARMACIE MINGNEAU earn?

The average wage cost per full-time employee at PHARMACIE MINGNEAU was € 55,000 in 2025: staff costs of € 137,594 for 2.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE MINGNEAU have?

According to the 2025 annual accounts, PHARMACIE MINGNEAU has 2.5 full-time equivalents (FTE).

PHARMACIE MINGNEAU (Public Limited) - Rumes

Dossier PHARMACIE MINGNEAU, printed on 29 October 2026 from databakkes.be/en/0443686314/pharmacie-mingneau. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 3.1 to 2.5.

Financials

Financial year 2025

PHARMACIE MINGNEAU from Rumes, company number BE0443686314, closed financial year 2025 with a result of € 80,038 after tax. For that financial year PHARMACIE MINGNEAU recorded a gross margin of € 408,078 and equity of € 244,197. Compared with financial year 2024, the result moved from € 25,953 to € 80,038. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.

What it is worth Growing

€ 244,197

▲ 49% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 80,038

▲ 208% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 110,790

▲ 116% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 182,197.

People and assets in 2025

Full-time equivalents

2.5

▼ 0.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 137,594

▼ 1% vs 2024

€ 55,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 6,542

▼ 23% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 15 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.4 million

▼ 6% vs 2024

€ 95,908 is repaid this year. At this pace the long-term loan is gone in ≈ 15 years.

Owed to suppliers

€ 107,952

▲ 76% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 48,078

▲ 135% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 248,893 Gross margin 2022: € 248,893 First fiscal year in the series	€ 245,469 Gross margin 2023: € 245,469 ▼ 1% vs 2022 (€ 248,893) Unfavourable step	€ 317,437 Gross margin 2024: € 317,437 ▲ 29% vs 2023 (€ 245,469) Favourable step	€ 408,078 Gross margin 2025: € 408,078 ▲ 29% vs 2024 (€ 317,437) Favourable step	▲ 29%
Profit after taxes	€ 67,720 Profit after taxes 2022: € 67,720 First fiscal year in the series	€ -34,782 Profit after taxes 2023: € -34,782 ▼ € 102,502 vs 2022 (€ 67,720) Unfavourable step	€ 25,953 Profit after taxes 2024: € 25,953 ▲ € 60,735 vs 2023 (€ -34,782) Favourable step	€ 80,038 Profit after taxes 2025: € 80,038 ▲ 208% vs 2024 (€ 25,953) Favourable step	▲ 208%
Equity	€ 172,989 Equity 2022: € 172,989 First fiscal year in the series	€ 138,207 Equity 2023: € 138,207 ▼ 20% vs 2022 (€ 172,989) Unfavourable step	€ 164,159 Equity 2024: € 164,159 ▲ 19% vs 2023 (€ 138,207) Favourable step	€ 244,197 Equity 2025: € 244,197 ▲ 49% vs 2024 (€ 164,159) Favourable step	▲ 49%
Total debts	€ 346,668 Total debts 2022: € 346,668 First fiscal year in the series	€ 1,456,011 Total debts 2023: € 1,456,011 ▲ € 1.1 million vs 2022 (€ 346,668) Unfavourable step	€ 1,642,559 Total debts 2024: € 1,642,559 ▲ 13% vs 2023 (€ 1,456,011) Unfavourable step	€ 1,625,118 Total debts 2025: € 1,625,118 ▼ 1% vs 2024 (€ 1,642,559) Favourable step	▼ 1%
Cash	€ 250,755 Cash 2022: € 250,755 First fiscal year in the series	€ 119,447 Cash 2023: € 119,447 ▼ 52% vs 2022 (€ 250,755) Unfavourable step	€ 51,266 Cash 2024: € 51,266 ▼ 57% vs 2023 (€ 119,447) Unfavourable step	€ 110,790 Cash 2025: € 110,790 ▲ 116% vs 2024 (€ 51,266) Favourable step	▲ 116%
Land & buildings	€ 121,980 Land & buildings 2022: € 121,980 First fiscal year in the series	€ 967,932 Land & buildings 2023: € 967,932 ▲ € 845,952 vs 2022 (€ 121,980) Unchanged	€ 1,092,073 Land & buildings 2024: € 1,092,073 ▲ 13% vs 2023 (€ 967,932) Unchanged	€ 1,051,499 Land & buildings 2025: € 1,051,499 ▼ 4% vs 2024 (€ 1,092,073) Unchanged	▼ 4%
Retained profit	€ 110,989 Retained profit 2022: € 110,989 First fiscal year in the series	€ 76,207 Retained profit 2023: € 76,207 ▼ 31% vs 2022 (€ 110,989) Unfavourable step	€ 102,159 Retained profit 2024: € 102,159 ▲ 34% vs 2023 (€ 76,207) Favourable step	€ 182,197 Retained profit 2025: € 182,197 ▲ 78% vs 2024 (€ 102,159) Favourable step	▲ 78%
Bank debt	€ 104,770 Bank debt 2022: € 104,770 First fiscal year in the series	€ 1,345,997 Bank debt 2023: € 1,345,997 ▲ € 1.2 million vs 2022 (€ 104,770) Unfavourable step	€ 1,520,272 Bank debt 2024: € 1,520,272 ▲ 13% vs 2023 (€ 1,345,997) Unfavourable step	€ 1,426,847 Bank debt 2025: € 1,426,847 ▼ 6% vs 2024 (€ 1,520,272) Favourable step	▼ 6%
Balance sheet total	€ 519,657 Balance sheet total 2022: € 519,657 First fiscal year in the series	€ 1,594,218 Balance sheet total 2023: € 1,594,218 ▲ 207% vs 2022 (€ 519,657) Unchanged	€ 1,806,718 Balance sheet total 2024: € 1,806,718 ▲ 13% vs 2023 (€ 1,594,218) Unchanged	€ 1,869,315 Balance sheet total 2025: € 1,869,315 ▲ 3% vs 2024 (€ 1,806,718) Unchanged	▲ 3%
Employees (FTE)	3.8 Employees (FTE) 2022: 3.8 First fiscal year in the series	3.1 Employees (FTE) 2023: 3.1 ▼ 0.7 vs 2022 (3.8) Unchanged	2.8 Employees (FTE) 2024: 2.8 ▼ 0.3 vs 2023 (3.1) Unchanged	2.5 Employees (FTE) 2025: 2.5 ▼ 0.3 vs 2024 (2.8) Unchanged	▼ 0.3

Key figures of PHARMACIE MINGNEAU, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE MINGNEAU?

What happened at PHARMACIE MINGNEAU in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Estelle Mingneau stepped down as director. NBB
Jun 25, 2026 New annual accounts for financial year 2025: profit of € 80,038 (▲ 208% vs 2024). Source: NBB ↗
2023 Estelle Mingneau became a director. NBB
May 8, 1991 New establishment in Rumes. KBO
Mar 15, 1991 Start of the company according to the CBE. KBO

In short

From € 67,720 profit in 2022 to € 80,038 profit in 2025.

Paid € 51,338 in corporate taxes since 2022.

Best year ever: 2025, with € 80,038 profit.

On average € 163,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

PHARMACIE LEQUENNE 95%

The stake of PHARMACIE LEQUENNE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE MINGNEAU

Behind PHARMACIE MINGNEAU are Marc Vander Massen and Martin Vander Massen. The shares are held by PHARMACIE LEQUENNE (95%).

Directors

According to the 2025 annual accounts

Marc Vander Massen

Director

Also active at: PHARMACIE LEQUENNE, SAINT-MARTIN, VENTIS, EOLIENNES DE LA FONTAINE, GOUYNRG

Martin Vander Massen

Director

Also active at: JIV Immo

Estelle Mingneau

Managing director

Also active at: JIV Immo

since 2023 · until 2029

Shareholders

PHARMACIE LEQUENNE

95%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée de Douai(RS) 92

7610 Rumes

2.052.679.752

Chaussée de Douai(RS) 47

7610 Rumes

Active since 8 May 1991

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0443.686.314

VAT number

BE 0443.686.314

Registered office

Chaussée de Douai(RS) 92, 7610 Rumes

Names & denominations

PHARMACIE MINGNEAU

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

15 March 1991

Peppol

Active · Active since 22 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE MINGNEAU

Warning lights

Financials

What happened to PHARMACIE MINGNEAU?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions